Search

everythinglearnresearchcommunity

for

Search:↓

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Dendrobium officinale polysaccharides may help with hair growth, skin moisturization, and protection against oxidative damage.

People with atopic dermatitis are more likely to develop other skin conditions due to shared genetics and immune pathways.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

Ingenol mebutate gel changes gene expression related to skin development and immune response in actinic keratosis.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Hemp seed biomaterials may reduce hair loss and improve hair growth.

Certain immune cells are linked to non-scarring hair loss, suggesting potential for immune-targeted treatments.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Mice treatments didn't grow hair, a patient treatment may affect immune response, and people with hair loss often feel anxious or depressed.

Found key genes affecting hair loss, immune response, and skin development; more research needed for better treatments.

Stress increases nerve fibers and immune cell activity in mouse skin, possibly worsening skin conditions.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

Hairless HRS/J mice resist Bacillus anthracis skin infections due to high numbers of immune cells, not because they lack hair follicles.

Tight junctions are key for skin protection and controlling what gets absorbed or passes through the skin.

Alopecia areata may be treated by restoring hair follicle immune privilege and adjusting immune responses.

Interleukin-15 can help hair growth and protect hair follicles.

Pantethine may boost the immune system's ability to fight sarcoma.

Fetal skin has unique immune cells different from adult skin.

The skin is vital for protection, temperature control, fluid balance, immunity, and sensing, with damage affecting daily life and mental health.